EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Allograft rejection is associated with development of functional IgE specific for donor MHC antigens



Allograft rejection is associated with development of functional IgE specific for donor MHC antigens



Journal of Allergy and Clinical Immunology 143(1): 335-345.E12



Donor-specific antibodies of the IgG isotype are measured routinely for diagnostic purposes in renal transplant recipients and are associated with antibody-mediated rejection and long-term graft loss. This study aimed to investigate whether MHC-specific antibodies of the IgE isotype are induced during allograft rejection. Anti-MHC/HLA IgE levels were measured in sera of mice grafted with skin or heart transplants from various donor strains and in sera of kidney transplant patients with high levels of HLA IgG. Mediator release was triggered in vitro by stimulating basophils that were coated with murine or human IgE-positive serum, respectively, with specific recombinant MHC/HLA antigens. Kidney tissue samples obtained from organ donors were analyzed by using flow cytometry for cells expressing the high-affinity receptor for IgE (FcεRI). Donor MHC class I- and MHC class II-specific IgE was found on acute rejection of skin and heart grafts in several murine strain combinations, as well as during chronic antibody-mediated heart graft rejection. Anti-HLA IgE, including donor HLA class I and II specificities, was identified in a group of sensitized transplant recipients. Murine and human anti-MHC/HLA IgE triggered mediator release in coated basophils on stimulation with specific MHC/HLA antigens. HLA-specific IgE was not linked to atopy, and allergen-specific IgE present in allergic patients did not cross-react with HLA antigens. FcεRI+ cells were found in the human renal cortex and medulla and provide targets for HLA-specific IgE. These results demonstrate that MHC/HLA-specific IgE develops during an alloresponse and is functional in mediating effector mechanisms.

(PDF emailed within 0-6 h: $19.90)

Accession: 045984736

Download citation: RISBibTeXText

PMID: 30009843

DOI: 10.1016/j.jaci.2018.06.034



Related references

The role of renal endothelial antigens and donor-specific antibodies in allograft rejection. Transplantation Proceedings 16(5): 1181-1181, 1984

A role for MHC antigens in donor-specific blood transfusion for the inhibition of liver allograft rejection in the rat. Transplantation 54(4): 750-752, 1992

Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies. Clinical and Experimental Immunology 178 Suppl 1: 59-60, 2015

Pre-transplant donor-specific transfusions induce allograft rejection and IL-2 gene expression in the WKY-->F344 functional tolerance model of rat lung transplantation. Transplant Immunology 6(3): 137-146, 1998

Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. American Journal of Transplantation 6(12): 2947-2954, 2006

CD4-mediated cardiac allograft rejection requires donor class II MHC antigens. Journal of Heart & Lung Transplantation 17(1): 64, 1998

The role of donor class i mhc antigens in renal allograft rejection in the mouse. Journal of the American Society of Nephrology 2(3): 780, 1991

Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection. Transplantation 69(4): 639-648, 2000

Prevention of chronic rejection by donor-specific blood transfusion in a new model of chronic cardiac allograft rejection. Transplantation 61(10): 1440-1443, 1996

Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. New England Journal of Medicine 300(22): 1258-1260, 1979

The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat. Transplantation 84(9): 1191-1199, 2007

Circulating CTL precursors with a high avidity for donor antigens reflect the rejection status of the human cardiac allograft. Journal of Heart & Lung Transplantation 16(1): 46, 1997

The duration of donor-specific hypersensitivity after human allograft rejection. Transplantation 36(4): 456-457, 1983

Specific inhibition of organ allograft rejection by donor blood. Transplantation Proceedings 3(1): 708-710, 1971

Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. European Journal of Cardio-Thoracic Surgery 18(4): 466-472, 2000